Authors
1 Department of Health Information Technology, School of Allied Medical Sciences, Lorestan University of Medical Sciences, Khorramabad, Iran
2 Bone and Joint Reconstruction Research Center, Department of Orthopedics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran Education Development Center, Iran University of Medical Sciences, Tehran, Iran ƗFirst authors: Ali Gravand and Nasim Aslani contributed equally to this study
3 Bone and Joint Reconstruction Research Center, Department of Orthopedics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
Abstract
Abstract:
The coronavirus disease 2019 (COVID‑19) pandemic has negatively affected the medical services,
particularly cancer diagnosis and treatment, for vulnerable cancer patients. Although lung cancer
has a high mortality rate, monitoring and following up of these patients can help to improve disease
management during the pandemic. Telemedicine has proven to be an effective method of providing
health care to these patients. As a result, the purpose of this study was to identify telemedicine
applications in the management of lung cancer patients during the COVID‑19 pandemic. In this scoping
review, studies published in online scientific databases such as Web of Science, Scopus, and PubMed
between January 1, 2020 and September 1, 2021 were systematically searched and screened. The
studies were chosen using predetermined inclusion and exclusion criteria. The bibliometric information
and technological aspects of included studies were collected using a data extraction form and the
data was analyzed using the content analysis approach. A total of 68 articles were found, from which
four articles were finally selected based on specific inclusion/exclusion criteria. Real‑time consultation
was one of the most common applications of telemedicine to deliver health‑care services to cancer
patients. Health‑care providers used applications such as Zoom, Facetime, WeChat, and e‑mail,
as well as devices including PCs, phones, and smartphones to provide real‑time consultation to
patients via videoconferencing, phone calls, and messaging, as well as store and forward consultation
via e‑mail. Telemedicine in the COVID‑19 pandemic provides health‑care services to lung cancer
patients at their homes by enabling physicians and patients to communicate in real time. Several
telemedicine services are still unavailable for patients with lung cancer. As a result, health experts,
politicians, and entrepreneurs must pay special attention to this issue.
Keywords
Zaman S, et al. Quality of Life (QoL) of cancer patients and its
association with nutritional and performance status: A pilot study.
Heliyon 2020;6:e05250.
2. Behmanesh A, Sadoughi F, Mazhar FN, Joghataei MT, Yazdani S.
Tele‑orthopaedics: A systematic mapping study. J Telemed
Telecare 2020;28:3‑23.
3. Sinha S, Kundu CN. Cancer and COVID‑19: Why are cancer
patients more susceptible to COVID‑19? Med Oncol 2021;38:1‑7.
doi: 10.1007/s12032‑021‑01553‑3.
4. Horn L, Garassino M. COVID‑19 in patients with cancer:
Managing a pandemic within a pandemic. Nat Rev Clin Oncol
2021;18:1‑2. doi: 10.1038/s41571‑020‑00441‑5.
5. Eastman, Peggy Survey Pinpoints Adverse Effects of COVID-19
Pandemic on Cancer Care, Oncol Times 2020;42:18-21. doi:
10.1097/01.COT.0000669708.82110.32
6. Passaro A, Bestvina C, Velez Velez M, Garassino MC, Garon E,
Peters S. Severity of COVID‑19 in patients with lung cancer:
Evidence and challenges. J Immunother Cancer 2021;9:e002266.
doi: 10.1136/jitc‑2020‑002266.
7. Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM,
Rivera DR, et al. Clinical impact of COVID‑19 on patients with
cancer (CCC19): A cohort study. Lancet 2020;395:1907‑18.
8. Guan W‑J, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical
characteristics of coronavirus disease 2019 in China. N Engl J Med
2020;382:1708‑20.
9. Barta JA, Powell CA, Wisnivesky JP. Global epidemiology of lung
cancer. Ann Glob Health 2019;85. doi: 10.5334/aogh. 2419.
10. Luo J, Rizvi H, Preeshagul IR, EggerJV, Hoyos D, Bandlamudi C,
et al. COVID‑19 in patients with lung cancer. Ann Oncol
2020;31:1386‑96.
11. England N. Cancer waiting times 2014. Available from: https://
www.cancerresearchuk.org/about-cancer/cancer-in-general/
treatment/access-to-treatment/waiting-times-after-diagnosis
12. Richards M, Anderson M, Carter P, Ebert BL, Mossialos E. The
impact of the COVID‑19 pandemic on cancer care. Nat Cancer
2020;1:565‑7.
13. Maringe C, Spicer J, Morris M, Purushotham A, Nolte E,
Sullivan R, et al. The impact of the COVID‑19 pandemic on cancer
deaths due to delays in diagnosis in England, UK: A national,
population‑based, modelling study. Lancet Oncol 2020;21:1023‑34.
14. Round T, L’Esperance V, Bayly J, Brain K, Dallas L, Edwards JG,
et al. COVID‑19 and the multidisciplinary care of patients with
lung cancer: An evidence‑based review and commentary. Br J
Cancer 2021;125:629‑40.
15. Aator L. Study Shows Increase in Lung Cancer Mortality, Decrease
in Diagnosis During COVID‑19 Pandemic. 2021. Available from:
https://www.cancernetwork.com/view/study‑shows‑increase
‑in‑lung‑cancer‑mortality‑decrease‑in‑diagnosis‑during
‑covid‑19‑pandemic. [Last accessed on 2021 Aug 08].
16. Badano LP, Dall’Armellina E, Monaghan MJ, Pepi M, Baldassi M,
Cinello M, et al. Real‑time three‑dimensional echocardiography:
Technological gadget or clinical tool? J Cardiovasc Med
2007;8:144‑62.
17. Aslani N, Garavand A. The role of telemedicine to control
CoVID-19. Arch Clin Infect Dis. 2020.
18. Dorsey ER, Topol EJ. Telemedicine 2020 and the next decade.
Lancet 2020;395:859. doi: 10.1016/S0140‑6736 (20) 30424‑4.
19. Sirintrapun SJ, Lopez AM. Telemedicine in cancer care. Am Soc
Clin Oncol Educ Book 2018;38:540‑5.
20. Pardolesi A, Gherzi L, Pastorino U. Telemedicine for
management of patients with lung cancer during COVID‑19 in
an Italian cancer institute: SmartDoc Project. Tumori J 2021. doi:
10.1177/03008916211012760.
21. Monaghesh E, Hajizadeh A. The role of telehealth during
COVID‑19 outbreak: A systematic review based on current
evidence. BMC Public Health 2020;20:p. 1‑9. doi: 10.1186/
s12889‑020‑09301‑4.
22. Peters MD, Godfrey C, McInerney P, Baldini Soares C, Khalil H,
Parker D. Scoping reviews. Joanna Briggs Institute reviewer’s
manual. 2017;2015:1-24.
23. Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D,
et al. PRISMA extension for scoping reviews (PRISMA‑ScR):
Checklist and explanation. Ann Intern Med 2018;169:467‑73.
24. Samadbeik M, Fatehi F, Braunstein M, Barry B, Saremian M,
Kalhor F, et al. Education and training on electronic medical
records (EMRs) for health care professionals and students:
A scoping review. Int J Med Inform 2020;142:104238. doi:
10.1016/j.ijmedinf. 2020.104238.
25. Chen ZJ, Liang WT, Liu Q, He R, Chen QC, Li QF, et al. Use of
a remote oncology pharmacy service platform for patients with
cancer during the COVID‑19 pandemic: Implementation and
user acceptance evaluation. J Med Intern Res 2021;23:e24619. doi:
10.2196/24619.
26. Snyder S, Silva RF, Whisenant MS, Milbury K .
Videoconferenced Yoga interventions for cancer patients and
their caregivers during the COVID‑19 pandemic: A report
from a clinician’s perspective. Integr Cancer Ther 2021;20. doi:
10.1177/15347354211019111
27. Narayanan S, Lopez G, Powers‑James C, Fellman BM,
Chunduru A, Li Y, et al. Integrative oncology consultations
delivered via telehealth in 2020 and in‑person in 2019: Paradigm
shift during the COVID‑19 world pandemic. Integr Cancer Ther
2021;20. doi: 10.1177/1534735421999101.
28. de Marinis F, AttiliI, Morganti S, Stati V, Spitaleri G, Gianoncelli L,
et al. Results of multilevel containment measures to better protect
lung cancer patients from COVID‑19: The IEO model. Front Oncol
2020;10:665. doi: 10.3389/fonc. 2020.00665.
29. Curigliano G. Cancer patients and risk of mortality for COVID‑19.
Cancer Cell 2020;38:161‑3.
30. Yu J, Ouyang W, Chua MLK, Xie C. SARS‑CoV‑2 transmission in
patients with cancer at a tertiary care hospital in Wuhan, China.
JAMA Oncol 2020;6:1108‑10.
31. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I,
Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates
of incidence and mortality worldwide for 36 cancers in 185
countries. CA Cancer J Clin 2021;71:209‑49.
32. Pang L, Liu Z, Lin S, Liu Z, Liu H, Mai Z, et al. The effects of
telemedicine on the quality of life of patients with lung cancer:
A systematic review and meta‑analysis. Ther Adv Chronic Dis
2020;11:2040622320961597. doi: 10.1177/2040622320961597.
33. Behmanesh A, Sayfouri N, Sadoughi F, Gomez C. Technological
Features of Internet of Things in Medicine: A Systematic Mapping
Study. Wirel Commun Mob Comput. 2020;2020:27.
)